Skip to main content
Food Safety

African swine fever

What is African swine fever?

African swine fever (ASF) is a devastating infectious disease of pigs, usually deadly. No vaccine exists to combat this virus. It does not affect humans nor does it affect other animal species other than pigs and wild boars. It can be transmitted either via direct animal contact or via dissemination of contaminated food (e.g. sausages or uncooked meat). See more information on ASF here: EFSA, OIE.

Where are we now? - See the factsheet.

Current Situation

For epidemiological information gathered through the EU Animal Disease Information System (ADIS), please see the "Notification System" page.

The agenda and the presentations of the points being discussed in the Standing Committee on Plants, Animals, Food and Feed (PAFF) can be found in the "Animal Health and Welfare regulatory committee" page.

Special control measures

Legislation:Commission Implementing Regulation (EU) 2021/605 of 7 April 2021 laying down special control measures for African swine fever was adopted by the Commission based on the new legal framework of Regulation (EU) 2016/429 ("Animal Health Law"). More information on this new legal framework can be found here.

Special control measures for African swine fever apply in the Union in addition to rules for the prevention and control of certain listed diseases laid down in Commission Delegated Regulation (EU) 2020/687.

EU zoning measures: based on the epidemiological situation of African swine fever, the areas affected by that disease in relevant Member States are listed as restricted zones I, II and III in Annex I to Commission Implementing Regulation (EU) 2021/605. The latest specific zoning measures that have been taken with respect to evolution of the African swine fever situation in the Union are included in Commission Implementing Regulation (EU) 2022/2348 of 01 December 2022, amending Annex I to Commission Implementing Regulation (EU) 2021/605 laying down special control measures for African swine fever.

The map summarising the zoning measures for African swine fever in the Union and an interactive tool for EU ASF zoning measures provide an indicative representation of restricted zones I, II and III listed in Annex I of Commission Implementing Regulation (EU) 2021/605 as last amended by Commission Implementing Regulation (EU) 2022/2348 of 01 December 2022.

List of approved establishments - applicable until 21 April 2021

(as was referred to in Article 12 of Commission Implementing Decision 2014/709/EU)

Approved establishments, listed by country

flag_bel.png

Belgium (BE)

flag_bgr.png

Bulgaria (BG)

  • Annex 1: List of establishments within Section I of the National Register
  • Annex 2: List of establishments within Section V of the National Register
  • Annex 3: List of establishments within Section VI of the National Register
  • Annex 4: List of establishments within Section IV of the National Register
  • Annex 5: List of establishments within Section XIII of the National Register
flag_est.png

Estonia (EE)

  • No establishments under "Article 12"
flag_deu.png

Germany (DE)

flag_hun.png

Hungary (HU)

  • No establishments under "Article 12"
flag_ita.png

Italy (IT)

flag_lva.png

Latvia (LV)

flag_ltu.png

Lithuania (LT)

flag_pol.png

Poland (PL)

flag_rou.png

Romania (RO)

flag_svk.png

Slovakia (SK)

Websites of competent authorities of Member States

(concerned with lists of designated establishments as referred to in Article 41 of Commission Implementing Regulation (EU) 2021/605 [under construction])

flag_bgr.png

Bulgaria (BG)

flag_est.png

Estonia (EE)

flag_deu.png

Germany (DE)

flag_hun.png

Hungary (HU)

flag_ita.png

Italy (IT)

flag_lva.png

Latvia (LV)

flag_ltu.png

Lithuania (LT)

flag_pol.png

Poland (PL)

flag_rou.png

Romania (RO)

flag_svk.png

Slovakia (SK)

NOTICE: The information on this site is for information purposes only. In case of errors, amendments or updates, the competent authority of each Member State should be contacted directly.

The EU legislation referenced above is fully in line with the OIE international standards. Nevertheless, in order to ensure a higher level of animal health protection, the EU goes beyond the OIE requirements and applies stricter standards in certain situations.

The working document SANTE/7112/2015 has been developed to lay down the principles and criteria for geographically and temporally defining ASF regionalisation.

Document SANTE/7113/2015 summarises the Strategic approach to the management of African Swine Fever for the EU. The ASF Strategic approach is aimed to the EU countries affected by the disease and to EU countries free from the disease with a risk of introduction. It is intended to prevent the spread of the disease and eventually to eradicate the disease in the affected territories. This strategic approach was developed and updated taking into account the latest findings from EFSA and experience gained.

These guidelines are currently being revised

BTSF training materials on African Swine Fever (ASF)

The BTSF (Better Training for Safer Food) initiative is actively participating in the fight again the ASF with the training of officials in the Member States and neighbouring countries.

Below, see the presentations for each of the sessions held on the ASF topic:

EFSA scientific advice

Relevant scientific advice on ASF has been provided by the European Food Safety Authority by means of the:

Blueprint and Roadmap (BRMP)

BRMP on the possible development of an African Swine Fever (ASF) vaccine.

The Commission has requested to the African Swine Fever EURL (specific mandate EU co-funded) to prepare a valuable document collecting all scientific work, identifying gaps and needs for possible vaccine development and proposing roads to achieve the final goal: the development of an effective and safe vaccine against ASF.

The aim of the ASF blueprint and roadmap is to give an overview of the research efforts needed and help to direct investments towards specific areas.

The STRATEGIC GOALS identified include:

  • Identification of potential strategies for vaccine development based on existing data/knowledge in a view of an effective and safe vaccine.
  • Identification of gaps and needs for vaccine development and manufacturing following the Good Manufacturing Practice Standards.
  • Identification of a network of dedicated laboratories directed towards vaccine development
  • Identification of the research steps (Roadmap)

ASF Diagnostics

Relevant information can be found on the website of EU Reference laboratory for ASF.

Further information